Literature DB >> 33800090

Measuring the Humoral Immune Response in Cats Exposed to Feline Leukaemia Virus.

Yasmin A Parr1, Melissa J Beall2, Julie K Levy3, Michael McDonald4, Natascha T Hamman5, Brian J Willett1, Margaret J Hosie1.   

Abstract

Retroviruses belong to an important and diverse family of RNA viruses capable of causing neoplastic disease in their hosts. Feline leukaemia virus (FeLV) is a gammaretrovirus that infects domestic and wild cats, causing immunodeficiency, cytopenia and neoplasia in progressively infected cats. The outcome of FeLV infection is influenced by the host immune response; progressively infected cats demonstrate weaker immune responses compared to regressively infected cats. In this study, humoral immune responses were examined in 180 samples collected from 123 domestic cats that had been naturally exposed to FeLV, using a novel ELISA to measure antibodies recognizing the FeLV surface unit (SU) glycoprotein in plasma samples. A correlation was demonstrated between the strength of the humoral immune response to the SU protein and the outcome of exposure. Cats with regressive infection demonstrated higher antibody responses to the SU protein compared to cats belonging to other outcome groups, and samples from cats with regressive infection contained virus neutralising antibodies. These results demonstrate that an ELISA that assesses the humoral response to FeLV SU complements the use of viral diagnostic tests to define the outcome of exposure to FeLV. Together these tests could allow the rapid identification of regressively infected cats that are unlikely to develop FeLV-related disease.

Entities:  

Keywords:  FeLV; SU antibody response; diagnostics; exposure outcomes; humoral immune response; retrovirus

Mesh:

Substances:

Year:  2021        PMID: 33800090      PMCID: PMC7998633          DOI: 10.3390/v13030428

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  35 in total

1.  One-step fluorescent probe product-enhanced reverse transcriptase assay.

Authors:  B A Arnold; R W Hepler; P M Keller
Journal:  Biotechniques       Date:  1998-07       Impact factor: 1.993

2.  Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats.

Authors:  Regina Hofmann-Lehmann; Jon B Huder; Sabine Gruber; Felicitas Boretti; Brigitte Sigrist; Hans Lutz
Journal:  J Gen Virol       Date:  2001-07       Impact factor: 3.891

3.  Seroprevalences of feline leukemia virus and feline immunodeficiency virus infection in cats in the United States and Canada and risk factors for seropositivity.

Authors:  Amie N Burling; Julie K Levy; H Morgan Scott; Michael M Crandall; Sylvia J Tucker; Erin G Wood; Jessie D Foster
Journal:  J Am Vet Med Assoc       Date:  2017-07-15       Impact factor: 1.936

4.  Serology in feline leukaemia virus infections.

Authors:  J O Jarrett
Journal:  Vet Rec       Date:  1981-05-23       Impact factor: 2.695

5.  Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus.

Authors:  H Lutz; N Pedersen; J Higgins; U Hübscher; F A Troy; G H Theilen
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

6.  Detection of feline leukemia virus infection in saliva.

Authors:  H Lutz; O Jarrett
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

7.  Rapid detection of feline leukemia virus provirus integration into feline genomic DNA.

Authors:  Valentino Cattori; Ravi Tandon; Andrea Pepin; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Mol Cell Probes       Date:  2006-02-20       Impact factor: 2.365

8.  Are endogenous feline leukemia viruses really endogenous?

Authors:  H Stewart; O Jarrett; M J Hosie; B J Willett
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

9.  Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding.

Authors:  O B Spiller; L Mark; C E Blue; D G Proctor; J A Aitken; A M Blom; D J Blackbourn
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 10.  Applications of quantitative PCR in the biosafety and genetic stability assessment of biotechnology products.

Authors:  Archie Lovatt
Journal:  J Biotechnol       Date:  2002-01       Impact factor: 3.307

View more
  2 in total

1.  Special Issue: Viral Infections in Companion Animals.

Authors:  Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2022-02-04       Impact factor: 5.818

Review 2.  Vaccination and Antibody Testing in Cats.

Authors:  Herman Egberink; Tadeusz Frymus; Katrin Hartmann; Karin Möstl; Diane D Addie; Sándor Belák; Corine Boucraut-Baralon; Regina Hofmann-Lehmann; Albert Lloret; Fulvio Marsilio; Maria Grazia Pennisi; Séverine Tasker; Etienne Thiry; Uwe Truyen; Margaret J Hosie
Journal:  Viruses       Date:  2022-07-22       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.